Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Intra-patient Randomised Controlled Multicentre International Study to Evaluate the Efficacy of an Acellular Dermal Template Novomaix for the Treatment of Full Thickness Skin Defects

NCT02373566 is registered in ClinicalTrials.gov with Association of Dutch Burn Centres as lead sponsor.

NCT NCT02373566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02373566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Intra-patient Randomised Controlled Multicentre International Study to Evaluate the Efficacy of an Acellular Dermal Template Novomaix for the Treatment of Full Thickness Skin Defects
Lead sponsor
Association of Dutch Burn Centres
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2015
Completion date
September 30, 2016
Enrollment
11 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

full thickness skin defects